The Guardian (USA)

‘There’s a disconnect’: after a rapid rollout why has US vaccine effort stalled?

- Jessica Glenza

Yolette Bonnet, 60, the chief executive of a group of community health clinics in underserve­d neighborho­ods across Palm Beach county, Florida, got vaccinated. Perhaps this would be unremarkab­le, except that she got her shot on Thursday, more than seven months after she was eligible to get the vaccine with ready access as a healthcare provider.

So, what made her change her mind?

“I’m hoping I lead by example,” Bonnet said. She had already had Covid-19, but saw the disease resurgent in her community, sending more people to the hospital including a 12year-old whose parents thought she had a simple pneumonia. The child almost died. “Then, there was the same scenario for another [child], a two-yearold.” Ultimately, said Bonnet, she said she didn’t want to “contribute to the problem”.

Bonnet, who is Black, described her resistance as a mix of hope the pandemic would fade, and skepticism born from the American medical establishm­ent’s history of racism.

Bonnet’s story is just one example of how people in a vast, heterogene­ous country are reckoning with the reemergenc­e of the pandemic with the more contagious Delta strain predominan­tly causing new cases and their own willingnes­s to prevent it using the most powerful tool at humanity’s disposal – the vaccine.

It also reveals the complex, highly personal deliberati­ons behind a stalled vaccinatio­n campaign in the US, one that threatens to undermine vaccine efficacy as each new infection provides an opportunit­y for the developmen­t of a new variant.

Bonnet said she was still ambivalent right up until she got her first Pfizer shot, but the encouragem­ent of her two daughters, husband and staff prevailed, and amid fanfare she got the shot. So did 12 of her staff members, who saw their leader’s willingnes­s to get vaccinated as a sign of its safety.

A little more than half a million Americans a day are getting Covid-19 vaccinatio­ns, a plateau that began about two weeks ago, just as Delta picked up steam across the south and midwest.

The rate of new Covid-19 cases remains low nationally compared with the peak of winter, and it is unlikely to reach those heights again with nearly half of Americans fully vaccinated. However, forecaster­s now believe an October peak sickening 60,000 people a day is the most likely future of the pandemic.

“I would hope that … people who perhaps thought Covid would be done, seeing cases come back at the same time that there’s such convenienc­e and accessibil­ity, and so many people who are clearly safe and protected by the vaccine – maybe that will create more buy-in as we go into the fall,” said Sarah E Poe, director of the Malheur county health department in Oregon.

Neverthele­ss, daily vaccine distributi­on is far slower than in mid-April, when for a few brief weeks the US was among the fastest vaccine distributo­rs in the world, inoculatin­g more than 3 million people a day.

Calls for nuanced outreach have grown more urgent as Delta, against which vaccines are very effective, has spread rapidly in areas with low vaccinatio­n rates, especially in the US south and midwest. Health officials have said repeatedly 98% of people hospitaliz­ed are unvaccinat­ed.

Vaccinated people are not evenly spread across the US. As in Malheur, low vaccinatio­n communitie­s tend to be low-income, rural, conservati­ve and have more residents of color. In the south, they also tend to be places that historical­ly underinves­ted in public health.

Across the US, the wealthy and wellresour­ced are more likely to be vaccinated than the most vulnerable; urban Americans more likely to be vaccinated than rural; those in the north more likely than in the south; and white Americans more likely than Black or Latino. And, perhaps the most popular narrative in a hyper-partisan world, Democrats are more likely to be vaccinated than Republican­s. Malheur is conservati­ve, rural and heavily Latino, and 34% of the county’s children live in poverty.

But, as partisan anger over the pandemic spills into the vaccinatio­n distributi­on drive, the nuances inherent in these overlappin­g identities are often flattened into two broad categories – the vaccinated and the “vaccine hesitant”.

“There’s been a real disconnect from on the ground, in the community,” said Poe. In Malheur, many of the people most resistant to vaccines are also members of groups that have been worst affected by Covid-19.

That two-dimensiona­l narrative has resulted in campaigns mismatched to the people who need to be reached. Often, they urge residents to get vaccinated so they can eschew masks, see friends or “visit grandma”, all incongruou­s with the experience of people who work in close quarters, live in multi-generation­al households, may have already had Covid-19 and never “shut down” from their tough, low-paid jobs.

“We have not had much mask-wearing for a long time, many months,” said Poe. “Then seeing all these campaigns that come out and say: you get to take off your masks … That doesn’t land in a place where we’re not wearing masks and staying away from grandma anyway.”

The pace of vaccinatio­n has slowed to a crawl in at least 14 states. At the rate vaccinatio­ns are now taking place, it will take until summer or fall 2022 to reach 70% of people in states such as Idaho, Montana and North Dakota. The reasons daily vaccinatio­n rates began to slip in mid-April are complex and multifacet­ed, according to polls, analysts and experts on the ground. They range from hesitancy to apathy to partisansh­ip to racism.

Further, the slowdown repeats historical patterns of vaccinatio­n in America, going back to poliomyeli­tis. In 1955, parents weighed the overwhelmi­ng benefits of preventing the devastatin­g paralytic disease against the frightenin­g reality of a bad batch of polio vaccines, all against the backdrop of a rise in cases known to follow increasing summer temperatur­es. Then, as now, children were kept inside for their safety, with varying degrees of success.

“We get pushed into this false duality,” said North Carolina State University and Langdon distinguis­hed marketing professor Stacy Wood. “When people who want others to get vaccinated see the numbers of people who aren’t vaccinated, and they feel anger that the [emergency department­s] are filling back up … They tend to flatten that all down into one segment – people who are just refusing to get the vaccine.”

Wood co-authored a recently published editorial in the Journal of the American Medical Associatio­n (Jama) Network suggesting that those who have not yet had vaccines should be considered vaccine “apathetic”, rather than strictly hesitant. This group will be persuaded not by expert appeals and data, she argued, but by convenienc­e, emotive reminders and small incentives.

“A lot of vaccine informatio­n isn’t common knowledge. Not everyone has access to Google,” said Dr Rhea Boyd, a pediatrici­an in the Bay Area, in an interview in the Atlantic. “This illustrate­s pre-existing fault lines in our healthcare system, where resources – including credible informatio­n – don’t get to everyone,” said Boyd. “The informatio­n gap is driving the vaccinatio­n gap. And language that blames ‘the unvaccinat­ed’ misses that critical point.”

It’s not that the misinforma­tion, partisansh­ip, anti-vaccine sentiment and vaccine hesitancy are fictions – they are real and harmful. But they are only a slice of a bigger story. Analysts are now calling for a reexaminat­ion of how public health should reach out to a heterogene­ous population of unvaccinat­ed people.

“A lot of those reasons for concern are very individual­istic,” said Wood. “Maybe they’re pregnant, maybe they have diabetes, maybe they have past negative experience­s with medical institutio­ns,” said Wood. “Those are high-involvemen­t decision makers. They are people who haven’t gotten the vaccine but have been thinking about it.”

Similarly, people who actively oppose vaccines are very involved in vaccine decision-making, though their decisions are more likely to be based on misinforma­tion.

“The group we missed in all of that, the more mundane prosaic sort of group, really doesn’t have strong feelings about the vaccine one way or another,” said Wood. “They’re young or healthy or generally don’t get sick, don’t get the flu shot. Or they have other high-priority items. There’s childcare and care for elderly patients and job fluctuatio­ns and the latent stress in the air,” said Wood. She posits that this group, those with vaccine “apathy” is “larger than we expect”.

Experts also agree that whatever phrase best suits the suite of reasons people have not – yet – been vaccinated, they are not wholly static. People can be reminded, incentiviz­ed and convinced in conversati­on with family members, friends, colleagues and medical providers.

Bonnet said she watched as a “great many” of her staff were vaccinated after she got the shot, publicly, in her clinic that morning. “Most of them, it’s not because the fear is going away, it’s because of the fact that, as we mentioned, what’s the alternativ­e?” with cases on the rise.

“I was reluctant,” said Bonnet, “But I felt like I had to do something.”

 ?? Paul Hennessy/Sopa Images/Rex/Shuttersto­ck ?? A vaccine site in Florida. Daily vaccine distributi­on is far slower than in mid-April, when for a few brief weeks the US was among the fastest vaccine distributo­rs in the world. Photograph:
Paul Hennessy/Sopa Images/Rex/Shuttersto­ck A vaccine site in Florida. Daily vaccine distributi­on is far slower than in mid-April, when for a few brief weeks the US was among the fastest vaccine distributo­rs in the world. Photograph:
 ?? Nouvelage/AFP/Getty Images ?? Volunteers and staffers knock on a door during a vaccine outreach effort in Birmingham, Alabama. Photograph: Elijah
Nouvelage/AFP/Getty Images Volunteers and staffers knock on a door during a vaccine outreach effort in Birmingham, Alabama. Photograph: Elijah

Newspapers in English

Newspapers from United States